{"id":6235,"date":"2026-02-14T13:27:08","date_gmt":"2026-02-14T13:27:08","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/6235\/"},"modified":"2026-02-14T13:27:08","modified_gmt":"2026-02-14T13:27:08","slug":"switzerlands-roche-flags-us-plans-after-trump-pharma-tariff-announcement","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/6235\/","title":{"rendered":"Switzerland’s Roche flags US plans after Trump pharma tariff announcement"},"content":{"rendered":"

Trump said on Thursday the United States will impose a 100% tariff on imports of branded or patented pharmaceutical products from October 1, unless a given pharmaceutical company is building a manufacturing plant in the US.\u00a0<\/p>\n

By Reuters\u00a0September 26, 2025, 4:29:42 PM IST (Published)<\/p>\n

2 Min Read<\/p>\n

\"CNBCTV18<\/a><\/a><\/p>\n

Switzerland’s Roche on Friday underlined that one of its US units recently broke ground on a new facility after President Donald Trump announced new pharmaceutical tariffs that were not due to apply to companies building US plants.<\/p>\n


<\/p>\n

Trump said on Thursday the United States will impose a 100% tariff on imports of branded or patented pharmaceutical products from October 1, unless a given pharmaceutical company is building a manufacturing plant in the US.<\/p>\n

<\/p>\n

A Roche spokesperson pointed to the August 25 announcement about its Genentech unit’s plans for a facility in Holly Springs, North Carolina, as well as Roche’s $50 billion pledge to invest in US manufacturing and research and development.<\/p>\n

Roche and Novartis are Switzerland’s two biggest pharmaceutical firms with major US production operations.<\/p>\n

Novartis, which also made a large US investment pledge\u00a0earlier this year, did not immediately reply to a request for comment.<\/p>\n

An industry source estimated that, based on the initial US indications, the tariffs as set out by Trump on Thursday would probably not apply to the two Swiss companies.<\/p>\n

<\/p>\n

Investors appeared to shrug off the news with shares in both Roche and Novartis trading slightly up early on Friday.<\/p>\n

The Swiss government said the relevant departments are analysing the potential impact of Trump’s pharmaceutical tariff measures but that it did not have details of them.<\/p>\n

<\/p>\n

Continue Reading<\/p>\n","protected":false},"excerpt":{"rendered":"Trump said on Thursday the United States will impose a 100% tariff on imports of branded or patented…\n","protected":false},"author":2,"featured_media":6236,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[18,5183,5196,5184,206,5194,5187,5186,5192,5195,5190,134,5193,5188,5181,5191,5185,5189,5182,25],"class_list":["post-6235","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-donald-trump","tag-genentech-facility","tag-global-pharma-news","tag-holly-springs-north-carolina","tag-novartis","tag-novartis-us-investment","tag-patented-drugs-tariffs","tag-pharma-industry-news","tag-pharma-stocks","tag-pharmaceutical-import-tariffs","tag-pharmaceutical-rd","tag-roche","tag-roche-us-operations","tag-swiss-pharmaceutical-companies","tag-switzerland-pharma","tag-trump-tariff-announcement","tag-us-manufacturing-investment","tag-us-pharma-plant","tag-us-pharmaceutical-tariffs","tag-us-trade-policy"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/6235","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=6235"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/6235\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/6236"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=6235"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=6235"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=6235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}